Page last updated: 2024-09-04

cp 55244 and sr141716

cp 55244 has been researched along with sr141716 in 3 studies

Compound Research Comparison

Studies
(cp 55244)
Trials
(cp 55244)
Recent Studies (post-2010)
(cp 55244)
Studies
(sr141716)
Trials
(sr141716)
Recent Studies (post-2010) (sr141716)
13012,22960631

Protein Interaction Comparison

ProteinTaxonomycp 55244 (IC50)sr141716 (IC50)
Bile salt export pumpHomo sapiens (human)10
Cytochrome P450 3A4Homo sapiens (human)0.0069
Cannabinoid receptor 1Rattus norvegicus (Norway rat)0.0081
Cannabinoid receptor 1Homo sapiens (human)0.0219
Cytochrome P450 2C19Homo sapiens (human)0.0069
Cannabinoid receptor 2 Homo sapiens (human)2.4666
Cannabinoid receptor 1Mus musculus (house mouse)0.025
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.108
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)3.795

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, AJ; Brown, J; Brown, S; Daniels, DA; Dowell, SJ; Haslam, CP; Kassim, M; Nichols, PL; Staton, PC; Terrell, VR; Wise, A1
Abood, ME; Griffin, G; Martin, BR; Wray, EJ1
Cartier, E; Edwards, JL; Howlett, AC; Shim, JY; Welsh, WJ1

Other Studies

3 other study(ies) available for cp 55244 and sr141716

ArticleYear
Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:1

    Topics: Dose-Response Relationship, Drug; Glycine Plasma Membrane Transport Proteins; HEK293 Cells; Humans; Piperazines; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Saccharomyces cerevisiae; Yeasts

2011
Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum.
    British journal of pharmacology, 1999, Volume: 128, Issue:3

    Topics: Allosteric Regulation; Animals; Benzoxazines; Cerebellum; Male; Morpholines; Naphthalenes; Piperidines; Protein Binding; Pyrazoles; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant

1999
Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.
    Journal of medicinal chemistry, 2002, Mar-28, Volume: 45, Issue:7

    Topics: Algorithms; Animals; Brain; Kinetics; Ligands; Models, Chemical; Models, Molecular; Naphthalenes; Piperidines; Protein Binding; Protein Conformation; Protons; Pyrazoles; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Software; Structure-Activity Relationship

2002